The Effects of Pulsed Radiation Therapy on Tumor Oxygenation in 2 Murine Models of Head and Neck Squamous Cell Carcinoma.

Abstract

PURPOSE:

To evaluate the efficacy of low-dose pulsed radiation therapy (PRT) in 2 head and neck squamous cell carcinoma (HNSCC) xenografts and to investigate the mechanism of action of PRT compared with standard radiation therapy (SRT).

METHODS AND MATERIALS:

Subcutaneous radiosensitive UT-SCC-14 and radioresistant UT-SCC-15 xenografts were established in athymic NIH III HO female mice. Tumors were irradiated with 2 Gy/day by continuous standard delivery (SRT: 2 Gy) or discontinuous low-dose pulsed delivery (PRT: 0.2 Gy × 10 with 3-min pulse interval) to total doses of 20 Gy (UT14) or 40 Gy (UT15) using a clinical 5-day on/2-day off schedule. Treatment response was assessed by changes in tumor volume, (18)F-fluorodeoxyglucose (FDG) (tumor metabolism), and (18)F-fluoromisonidazole (FMISO) (hypoxia) positron emission tomography (PET) imaging before, at midpoint, and after treatment. Tumor hypoxia using pimonidazole staining and vascular density (CD34 staining) were assessed by quantitative histopathology.

RESULTS:

UT15 and UT14 tumors responded similarly in terms of growth delay to either SRT or PRT. When compared with UT14 tumors, UT15 tumors demonstrated significantly lower uptake of FDG at all time points after irradiation. UT14 tumors demonstrated higher levels of tumor hypoxia after SRT when compared with PRT as measured by (18)F-FMISO PET. By contrast, no differences were seen in (18)F-FMISO PET imaging between SRT and PRT for UT15 tumors. Histologic analysis of pimonidazole staining mimicked the (18)F-FMISO PET imaging data, showing an increase in hypoxia in SRT-treated UT14 tumors but not PRT-treated tumors.

CONCLUSIONS:

Differences in (18)F-FMISO uptake for UT14 tumors after radiation therapy between PRT and SRT were measurable despite the similar tumor growth delay responses. In UT15 tumors, both SRT and PRT were equally effective at reducing tumor hypoxia to a significant level as measured by (18)F-FMISO and pimonidazole.

• Authors: Jessica Wobb, Sarah A Krueger, Jonathan L Kane, Sandra Galoforo, Inga S Grills, George D Wilson, Brian Marples
• Journal: International journal of radiation oncology, biology, physics (Int J Radiat Oncol Biol Phys) Vol. 92 Issue 4 Pg. 820-8 (Jul 15 2015) ISSN: 1879-355X [Electronic] United States
• PMID: 26104936 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: Copyright © 2015 Elsevier Inc. All rights reserved.

Chemical References

• Coloring Agents
• Nitroimidazoles
• Radiopharmaceuticals
• fluoromisonidazole
• Fluorodeoxyglucose F18
• pimonidazole
• Misonidazole

Topics

• Animals
• Carcinoma, Squamous Cell (blood supply, metabolism, pathology, radiotherapy)
• Cell Hypoxia
• Coloring Agents
• Disease Models, Animal
• Female
• Fluorodeoxyglucose F18 (pharmacokinetics)
• Head and Neck Neoplasms (blood supply, metabolism, pathology, radiotherapy)
• Heterografts
• Mice
• Mice, Nude
• Misonidazole (analogs & derivatives, pharmacokinetics)
• Neoplasm Recurrence, Local
• Nitroimidazoles
• Oxygen Consumption (radiation effects)
• Positron-Emission Tomography (methods)
• Radiopharmaceuticals (pharmacokinetics)
• Squamous Cell Carcinoma of Head and Neck
• Tumor Burden (radiation effects)